Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 37,500 shares at $65.27 ($2.5M) on 2024-04-15, disclosed to the SEC on 2024-04-17.
Scheduled sale ($2.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.27 | 25,600 | $1.7M | 68.0% |
| 2 | $66.17 | 11,900 | $787K | 32.0% |
| Total | $65.56 avg | 37,500 | $2.5M | 100% |
| Filing → |
| NUVL | SELL | 2025-02-25 | $265K | — | Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |